MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
39.03
+0.63
+1.64%
Closed 16:00 05/16 EDT
OPEN
38.27
PREV CLOSE
38.40
HIGH
39.03
LOW
38.26
VOLUME
275.18K
TURNOVER
10.66M
52 WEEK HIGH
42.85
52 WEEK LOW
29.08
MARKET CAP
199.96B
P/E (TTM)
27.45
1D
5D
1M
3M
1Y
5Y
1D
ANALYSIS-Novo Nordisk should look to the US for its next CEO, analysts say
Reuters · 17h ago
Sector Spotlight: Trump executive order targets drug prices
TipRanks · 17h ago
'FDA Clears First Blood Test Used In Diagnosing Alzheimer's Disease; New Test Provides Less Invasive Option, Reduces Reliance On Pet Scans And Increases Diagnosis Accessibility' - FDA
Benzinga · 19h ago
Berenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)
TipRanks · 1d ago
Zealand CEO: Oral weight loss meds are not the future for treating obesity
Seeking Alpha · 1d ago
RFK Jr. aide: GLP-1 weight loss meds will cost the same as in least expensive countries
Seeking Alpha · 1d ago
SA Asks: Would Trump's drug price cuts hurt biotech more than pharma?
Seeking Alpha · 1d ago
Merck Data Shows Positive Outcomes For Ovarian Cancer Patients Treated With Keytruda
Benzinga · 1d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.